A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma
Clinical trial NCT06472895 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06472895
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-20
- Primary completion
- 2025-12-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.